Moody National Bank Trust Division Purchases 885 Shares of CVS Health Co. (NYSE:CVS)

Moody National Bank Trust Division raised its holdings in shares of CVS Health Co. (NYSE:CVS) by 3.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 24,185 shares of the pharmacy operator’s stock after acquiring an additional 885 shares during the quarter. Moody National Bank Trust Division’s holdings in CVS Health were worth $1,086,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. American Century Companies Inc. raised its position in shares of CVS Health by 3.0% during the second quarter. American Century Companies Inc. now owns 968,121 shares of the pharmacy operator’s stock valued at $57,177,000 after buying an additional 28,250 shares during the last quarter. Thoroughbred Financial Services LLC increased its holdings in shares of CVS Health by 31.8% in the second quarter. Thoroughbred Financial Services LLC now owns 4,007 shares of the pharmacy operator’s stock worth $236,000 after purchasing an additional 967 shares during the last quarter. Fairfield Financial Advisors LTD bought a new position in CVS Health during the second quarter valued at approximately $40,000. Oldfield Partners LLP grew its holdings in CVS Health by 37.8% during the 2nd quarter. Oldfield Partners LLP now owns 6,200 shares of the pharmacy operator’s stock valued at $366,000 after buying an additional 1,700 shares in the last quarter. Finally, Waycross Partners LLC increased its stake in CVS Health by 11.3% in the 2nd quarter. Waycross Partners LLC now owns 207,539 shares of the pharmacy operator’s stock worth $12,257,000 after acquiring an additional 21,135 shares during the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts recently weighed in on CVS shares. Wells Fargo & Company raised shares of CVS Health from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $60.00 to $66.00 in a report on Monday, November 18th. TD Cowen lifted their price objective on shares of CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research note on Monday, November 25th. Evercore ISI upped their target price on shares of CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a research report on Tuesday, October 8th. UBS Group lifted their price target on CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research report on Thursday, November 7th. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $62.00 price objective on shares of CVS Health in a research note on Tuesday, October 1st. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $68.71.

CVS Health Stock Performance

Shares of NYSE:CVS opened at $51.54 on Tuesday. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The firm has a market cap of $64.86 billion, a PE ratio of 13.08, a price-to-earnings-growth ratio of 0.85 and a beta of 0.59. The firm’s 50 day simple moving average is $51.76 and its 200-day simple moving average is $56.49. CVS Health Co. has a one year low of $43.56 and a one year high of $80.75.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.08 by $0.01. The company had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm’s quarterly revenue was up 6.3% on a year-over-year basis. During the same period in the prior year, the business earned $2.21 EPS. As a group, equities analysts predict that CVS Health Co. will post 5.32 EPS for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 5.16%. The ex-dividend date of this dividend is Thursday, January 23rd. CVS Health’s payout ratio is 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.